Table 2

Outcome measures amongst eGFR groups.

OutcomesEstimated GFR (eGFR) levelsp-valueAdjusted OROR, 95% C. I. (Lower – Upper)
>60 mL/min/1.73 m2 (n=596)≤ 60 mL/min/1.73 m2 (n=131)
Death17 (2.9)14 (10.7)0.0023.772(1.609 – 8.844)
Composite outcome147 (24.7)56 (42.7)0.0091.781(1.153 – 2.751)
In hospital complications
 Pneumonia37 (6.2)8 (6.1)0.7330.866(0.380 – 1.976)
 UTI30 (5.0)17 (13.0)0.0432.047(1.024 – 4.093)
 VTE (DVT/PE)12 (2.0)1 (0.8)0.2240.267(0.032– 2.243)
 Fall15 (2.5)1 (0.8)0.2200.276(0.035 – 2.158)
 Bedsore4 (0.7)5 (3.8)0.0973.466(0.800 – 15.010)
 Recurrence of stroke/ TIA59 (9.9)22 (16.8)0.1801.476(0.835 – 2.609)
 Neurological deterioration38 (6.4)14 (10.7)0.2431.514(0.755 – 3.038)
mRS disability category post-stroke at discharge
 Mildly disabled (0-2)406 (72.6)71 (61.7)0.010
 Moderately to severely disabled (3-6)153 (27.4)44 (38.3)
 NIHSS value at discharge, mean±SD4.18±7.5677.14±11.8820.011
NIHSS severity category at discharge
 Mild stroke (≤ 5)448 (80.1)83 (72.2)0.011
 Moderate stroke (6 - 14)63 (11.3)18 (15.7)
 Severe stroke (>14)48 (8.6)14 (12.2)
  • eGFR - estimated glomerular filtration rate, UTI - urinary track infection, VTE - venous thromboembolism, DVT - deep venous thrombosis, PE - pulmonary embolism, TIA - transient ischemic attacks, mRS - modified Rankin Scale, NIHSS - National Institute of Health Stroke Score, Values are expressed as numbers and percentage n (%)